Immix Biopharma, Inc. Other Assets, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Other Assets, Current $279.17K.
- 2026-03-31: Other Assets, Current $335.74K.
- 2025-12-31: Other Assets, Current $150.72K.
- 2025-09-30: Other Assets, Current $132.76K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $279.17K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $335.74K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $150.72K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $132.76K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $137.70K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $168.40K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $32.27K 10-K/A · filed 2026-03-27 |
| 2024-09-30 | $36.52K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $105.78K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $175.25K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $44.58K 10-K · filed 2025-03-25 |
| 2023-09-30 | $167.00K 10-Q · filed 2023-11-13 |
| 2022-12-31 | $78.07K 10-K · filed 2024-03-29 |